Tarsons Products

Tarsons Products

315.60
+0.95
(0.30%)
Market Cap
1,679.19 Cr
EPS
5.60
PE Ratio
60.71
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
491.80
52 Week Low
280.00
PB Ratio
2.66
Debt to Equity
0.49
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,995.70
#1 20,221.57
55.46
#1 1,759.00
24.59
#1 339
25.81
39.67
311.30
1,710.97
75.07
236.56
19.23
29
-50.60
22.32
315.60
#3 1,679.19
#7 60.71
#2 408.40
#7 -0.45
#2 30
#7 -55.00
31.01
605.00
1,005.62
60.82
249.37
40.00
17
-20.59
41.13
588.30
948.88
46.40
186.60
#1 61.83
20
-
65.50
585.10
702.31
38.25
67.10
30.58
18
18.92
60.75
281.45
535.88
#1 31.00
136.30
-
16
-
82.39
333.30
347.99
43.11
111.80
-1.43
8
-0.10
93.13
291.00
305.94
39.16
89.85
0.60
7
#1 752.54
66.37
256.80
256.80
-
122.10
19.24
1
-52.94
57.28

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
-0.45 %
Net Income Growth
-57.70 %
Cash Flow Change
11.23 %
ROE
-66.13 %
ROCE
-65.83 %
EBITDA Margin (Avg.)
-30.63 %

Quarterly Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
62
68
71
77
73
88
65
109
88
108
97
117
95
Expenses
30
33
32
38
38
41
39
76
66
74
66
76
67
EBITDA
32
36
39
40
36
47
26
34
22
34
31
41
28
Operating Profit %
51 %
52 %
53 %
50 %
47 %
52 %
37 %
29 %
22 %
26 %
31 %
33 %
27 %
Depreciation
4
3
5
5
5
7
10
12
11
14
17
20
20
Interest
1
1
1
2
1
0
3
4
4
5
5
5
5
Profit Before Tax
28
32
33
34
29
39
14
17
6
15
8
16
3
Tax
7
8
9
9
7
10
4
7
2
5
3
5
1
Net Profit
21
24
25
25
22
30
10
10
4
10
5
10
2
EPS in ₹
4.13
4.59
4.88
4.89
4.14
5.69
1.87
1.94
0.75
1.93
0.99
1.92
0.34

Balance Sheet

Balance Sheet
2021
2022
2024
2025
Total Assets
296
544
972
1,080
Fixed Assets
120
189
336
536
Current Assets
113
245
235
243
Capital Work in Progress
22
32
267
233
Investments
0
0
0
0
Other Assets
153
323
369
311
Total Liabilities
296
544
972
1,080
Current Liabilities
42
35
213
176
Non Current Liabilities
10
20
146
274
Total Equity
244
490
613
630
Reserve & Surplus
244
479
602
620
Share Capital
0
11
11
11

Cash Flow

Cash Flow
2021
2022
2024
2025
Net Cash Flow
-23
75
-47
8
Investing Activities
-64
-138
-285
-145
Operating Activities
68
84
103
114
Financing Activities
-27
130
136
39

Share Holding

% Holding
Aug 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
50.99 %
47.30 %
47.30 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
47.31 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.16 %
7.95 %
8.04 %
7.51 %
9.52 %
9.14 %
DIIs
0.00 %
6.92 %
6.03 %
7.66 %
7.39 %
8.13 %
8.52 %
8.45 %
7.38 %
3.16 %
2.15 %
0.18 %
0.12 %
0.21 %
0.50 %
0.29 %
0.04 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
13.55 %
11.50 %
10.28 %
9.94 %
9.19 %
9.56 %
10.00 %
11.35 %
11.64 %
12.77 %
13.44 %
13.53 %
13.06 %
15.37 %
15.30 %
15.42 %
Others
49.01 %
32.23 %
35.17 %
34.75 %
35.36 %
35.37 %
34.62 %
34.25 %
33.96 %
37.90 %
37.78 %
30.92 %
31.10 %
31.39 %
29.31 %
27.58 %
28.09 %
No of Share Holders
8
61
1,59,891
1,25,714
1,12,227
1,07,011
1,07,945
1,05,304
1,07,440
1,08,236
1,07,564
1,02,866
1,05,330
99,586
96,927
93,417
90,891

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.66 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
22 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
22 Sept 2025 373.10 314.50
20 Sept 2024 DIVIDEND Dividend
₹ 2.00 /share
20 Sept 2024 418.95 468.70
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 465.20 452.15
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 406.65 419.00
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 364.55 329.95
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 386.30 431.20
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 371.20 373.10

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 31, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 30, 2025
Notice Of The 42Nd Annual General Meeting Of The Company For The Financial Year Ended 31St March 2025.Aug 30, 2025
Reg. 34 (1) Annual Report.Aug 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 27, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 22, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 12, 2025
Announcement Under Regulation 30 (LODR) Regulations 2015Aug 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 12, 2025
Adoption Of Unaudited Financial Results For The Quarter Ended 30Th June 2025Aug 12, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday 12Th August 2025 For The Quarter Ended 30Th June 2025.Aug 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 06, 2025
Board Meeting Intimation for Considering And Approving The Unaudited Standalone & Consolidated Financial Results Of The Company For The First Quarter Ended 30Th June 2025.Aug 06, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorAug 04, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 04, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 04, 2025
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Jul 23, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJul 23, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Closure of Trading WindowJun 25, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJun 21, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJun 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 03, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 29, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 29, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 28, 2025
Approved Annual Audited Financial Results For The Year Ended 31St March 2025May 28, 2025
Board Meeting Outcome for Approved The Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended 31St March 2025May 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 25, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 24, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 24, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2025
Board Meeting Intimation for Intimation Of Notice Of Board MeetingMay 22, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 20, 2025
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015May 07, 2025
Regulation 30 Of SEBI LODR Regulations 2015Apr 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Closure of Trading WindowMar 27, 2025
Announcement Under Regulation 30 Of SEBI LODRMar 19, 2025
Announcement Under Regulation 30Feb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025

Technical Indicators

RSI(14)
Neutral
31.01
ATR(14)
Less Volatile
10.94
STOCH(9,6)
Neutral
43.86
STOCH RSI(14)
Overbought
82.70
MACD(12,26)
Bullish
1.01
ADX(14)
Strong Trend
33.05
UO(9)
Bullish
28.99
ROC(12)
Downtrend And Accelerating
-3.92
WillR(14)
Neutral
-77.17

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.04%
-1
0.00%
-0.01%